組氨酸豐富糖蛋白(HRG)活性蛋白
Active Histidine Rich Glycoprotein (HRG)
HPRG; HRGP; Histidine-Proline Rich Glycoprotein; Thrombophilia Due To Elevated HRG
- 編號UAPC534Hu61
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點7.0
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 634 ¥ 1584 ¥ 3168 ¥ 9504 ¥ 23760
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Gene sequencing
-
Figure. SDS-PAGE
-
WB圖
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
活性實驗
Human histidine-rich glycoprotein (HRG) is a multidomain, monomeric, secreted, 67-75 kDa member of the cystatin superfamily of molecules. Its name derives from the fact that 26% of its amino acids (aa) are histidine and proline. In human, it is synthesized as a 525?aa precursor that contains an 18 aa signal sequence and a 507 aa mature region. Five distinct domains are recognized in the mature molecule. As HRG has the function of cell adhesion, we measure the activity of recombinant human HRG by the ability of the immobilized protein to support the adhesion of con-A activated MOLT 4 human acute lymphoblastic leukemia cells. When 1 x 105?cells/well with 7.5 ug/ml conA are added to recombinat human HRG coated plates (0.1 μg/mL with 100 μL/well), >70% cells will adhere after 2?hour incubation at 37 ℃. The adhesion of MOLT-4 after 2?hour incubation at 37 ℃ observed by inverted microscope was shown in Figure 1.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPC534Hu01 | 組氨酸豐富糖蛋白(HRG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPC534Hu61 | 組氨酸豐富糖蛋白(HRG)活性蛋白 | Cell?culture;?Activity?Assays. |
| UEPC534Hu61 | 組氨酸豐富糖蛋白(HRG)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAC534Hu01 | 組氨酸豐富糖蛋白(HRG)多克隆抗體 | WB; IHC |
| ULAC534Hu71 | 組氨酸豐富糖蛋白(HRG)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| UMAC534Hu24 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB |
| UMAC534Hu22 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB; IHC |
| UMAC534Hu21 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | IHC |
| UMAC534Hu23 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | IHC |
| UMAC534Hu26 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | IHC |
| USEC534Hu | 組氨酸豐富糖蛋白(HRG)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMC534Hu | 組氨酸豐富糖蛋白(HRG)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| J. Proteome Res. | Identification and Confirmation of Differentially Expressed Fucosylated Glycoproteins in the Serum of Ovarian Cancer Patients Using a Lectin Array and LC–MS/MS [ACS: pr300330z] |
| Medical Oncology | Evaluation of histidine-rich glycoprotein tissue RNA and serum protein as novel markers for breast cancer [Springer: Source] |
| Int J Cancer | The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine‐rich glycoprotein [PubMed: 25363753] |
| Nucleic Acid Therapeutics | Pharmacokinetic and Pharmacodynamic Investigations of ION-353382, a Model Antisense Oligonucleotide: Using Alpha-2-Macroglobulin and Murinoglobulin Double-Knockout Mice [Pubmed:27031383] |
| United States Patent Application | Compositions and Methods for Diagnosing Lung Cancer [y2016:0077095.html] |
| Hypertension?Research | Combination of serum histidine-rich glycoprotein and uterine artery Doppler to predict preeclampsia [Pubmed:29416108] |
| journal of histochemistry & cytochemistry | Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase [Pubmed: 31880188] |
| DOKLADY BIOCHEMISTRY AND BIOPHYSICS | Personalized Approach to Determination of Histidine-Rich Glycoprotein and E-Cadherin in Supernatants of Immunocompetent Blood Cells and Breast Biopsy … [Pubmed: 32342301] |
